Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Monocentric, Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Nitazoxanide at 500mg Twice Daily on Collagen Turnover in Plasma in NASH Patients With Fibrosis Stage 2 or 3

NCT03656068 is registered in ClinicalTrials.gov with Pinnacle Clinical Research, PLLC as lead sponsor.

NCT NCT03656068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Monocentric, Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Nitazoxanide at 500mg Twice Daily on Collagen Turnover in Plasma in NASH Patients With Fibrosis Stage 2 or 3
Lead sponsor
Pinnacle Clinical Research, PLLC
Phase
Phase 2
Overall status
Completed
Start date
December 4, 2018
Completion date
November 25, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

compensated cirrhosis, fatty liver, fibrosis, liver, non-alcoholic steatohepatitis